Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Trending Stock Alerts

HOLX Stock - Hologic Stock Trading


home / stock / holx

HOLX HOLX Quote HOLX Short HOLX News HOLX Articles HOLX Message Board

MWN AI Summary *

Hologic Inc. (NASDAQ: HOLX) is a prominent health and diagnostics company based in Marlborough, Massachusetts, known for its focus on women's health. Established in 1982, the company has carved out a niche in the medical device industry with a strong portfolio that includes diagnostic products, medical imaging systems, and surgical devices.

The company's products predominantly target conditions related to women's health, such as breast cancer, cervical cancer, and osteoporosis. Hologic's innovative technology includes a range of mammography systems, such as the Genius™ 3D Mammography™ system, which offers advanced imaging capabilities to enhance breast cancer detection rates. Additionally, the company provides molecular diagnostics solutions for infectious diseases, which gained significant traction during the COVID-19 pandemic.

Hologic's financial performance has been robust, particularly during the pandemic, as demand for its COVID-19 testing solutions surged. The company has consistently reported strong revenue growth, driven by its expanding product offerings and a commitment to research and development. As of late 2023, Hologic continues to invest heavily in innovation, aiming to enhance its existing product lines and develop new technologies to address unmet medical needs.

Moreover, Hologic has made strides in sustainability and corporate social responsibility, further solidifying its position as a leader in women's health. The company is focused on expanding its international presence and has engaged in strategic acquisitions to enhance its capabilities and market reach.

As investors assess Hologic's future potential, the company's commitment to innovation, its solid financial track record, and its strategic focus on women's health position it favorably in the healthcare market. As it navigates the post-pandemic landscape, Hologic remains a key player in advancing medical technologies and improving patient outcomes.

MWN AI Analysis *

Hologic Inc. (NASDAQ: HOLX) is a leading global medical technology company focused on women's health, offering a robust portfolio that includes diagnostic products, surgical interventions, and medical imaging solutions. As of October 2023, Hologic’s stock has shown resilience and growth potential, making it a compelling option for investors, particularly in the context of ongoing healthcare demands.

The company's strong emphasis on innovation, particularly in molecular diagnostics, has positioned Hologic favorably in the rapidly evolving medical landscape. With increasing focus on preventative care and early detection of diseases, Hologic’s diagnostic solutions are poised to benefit from rising market demand. The continued importance of COVID-19 testing, alongside its established expertise in cervical and breast health, enhances its revenue diversity and stability.

Financially, Hologic has demonstrated solid performance metrics. The company reported robust earnings growth in its recent quarterly results, driven by strong sales across its diagnostic and surgical segments. Its commitment to research and development will likely yield new product releases that can capture additional market share, especially given trends towards personalized medicine and advanced diagnostics.

Investors should also consider Hologic's strategic moves toward enhancing operational efficiency and expanding into international markets. These initiatives aim to mitigate risks associated with domestic market saturation and provide avenues for future revenue growth.

However, potential investors should remain cautious of broader macroeconomic factors, including inflation and interest rate fluctuations that may impact the healthcare sector. Nevertheless, Hologic’s fundamentals appear strong, bolstered by its leadership in women's health and commitment to innovation.

In conclusion, Hologic Inc. presents an attractive investment opportunity for those looking to capitalize on the healthcare sector's growth. Analysts recommend a "hold" or "buy" rating, considering the company’s positive growth trajectory and the essential nature of its product offerings. As always, investors should conduct further due diligence based on their individual financial situations and risk tolerance.

* MWN AI Summary and Analysis is based on asking OpenAI to summarize and analyze the company and stock symbol.


About | Hologic Inc. (NASDAQ:HOLX)

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Quote | Hologic Inc. (NASDAQ:HOLX)

Last:$64.90
Change Percent: 0.31%
Open:$64.17
Close:$64.90
High:$65.2
Low:$64.17
Volume:2,207,404
Last Trade Date Time:07/08/2025 03:40:43 pm

News | Hologic Inc. (NASDAQ:HOLX)

  • Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

    Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2025 on Wednesday, July 30, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. ...

    • July 02, 2025 04:05:00 pm

    • |
    • Business Wire
    • |
      • HOLX Stock
      • HOLX Quote
      • HOLX Short
      • HOLX News
      • HOLX Articles
      • HOLX Message Board
  • Notable healthcare headlines for the week: AstraZeneca, Eli Lilly, Bristol Myers in focus

    2025-06-01 09:05:23 ET Wall Street on Friday posted a strong monthly advance, though stocks finished mixed on the final day of May after U.S. President Donald Trump said China had "totally violated" a trade truce. ... Read the full article on Seeking Alpha For further detai...

    • June 01, 2025 09:05:23 am

    • |
    • SeekingAlpha
    • |
      • HOLX Stock
      • HOLX Quote
      • HOLX Short
      • HOLX News
      • HOLX Articles
      • HOLX Message Board

Message Board Posts | Hologic Inc. (NASDAQ:HOLX)

Subject By Source When
whytestocks: $HOLX News Article - Hologic Announces Contract with BARDA to Support IVD Approval of C whytestocks investorshangout 11/02/2022 7:41:24 PM
whytestocks: $HOLX News Article - Hologic (HOLX) Trading Report whytestocks investorshangout 07/22/2021 7:30:47 PM
Wish I still had my HOLX from when TruckingAngler investorshub 02/03/2021 11:31:50 PM
whytestocks: $HOLX News Article - Hologic Announces Preliminary Financial Results for First Quarter whytestocks investorshangout 01/08/2021 7:20:49 PM
whytestocks: $HOLX News Article - Hologic to Showcase Products Across Breast Cancer Screening, Biops whytestocks investorshangout 11/27/2020 7:05:46 PM

MWN AI FAQ **

What innovative products are driving revenue growth for Hologic Inc. (NASDAQ: HOLX) in the diagnostics and medical imaging sectors, and how do they compare to competitors in the market?

Hologic Inc. is experiencing revenue growth through innovative products like the Panther Fusion diagnostic system and 3D mammography, which outperform competitors by offering faster results and enhanced imaging accuracy, bolstering its market position.

How is Hologic Inc. HOLX positioned to adapt to regulatory changes and shifts in healthcare policies that could impact its operations and profitability?

Hologic Inc. is well-positioned to adapt to regulatory changes and shifts in healthcare policies through its diverse portfolio of diagnostic and surgical technologies, strong focus on innovation, and proactive engagement with regulatory bodies to ensure compliance and capitalize on emerging opportunities.

What are the key challenges and opportunities facing Hologic Inc. (NASDAQ: HOLX) as it expands its presence in international markets?

Hologic Inc. faces challenges such as navigating regulatory complexities and varying healthcare infrastructures while seizing opportunities in global demand for women's health products and innovations in diagnostics and imaging technologies.

How has Hologic Inc. HOLX structured its research and development efforts to maintain a competitive edge in women's health and diagnostics technology?

Hologic Inc. (HOLX) has structured its R&D efforts by focusing on innovative technologies in women's health, fostering collaborations with healthcare professionals, investing in advanced diagnostic tools, and prioritizing unmet medical needs to maintain a competitive edge in the market.

** MWN AI Questions are based on asking OpenAI to ask and answer four questions about the company and stock symbol.

Stock Information

Get HOLX Alerts

News, Short Squeeze, Breakout and More Instantly...

Hologic Inc. Company Name:

HOLX Stock Symbol:

NASDAQ Market:

0.31% G/L:

$64.90 Last:

2,207,404 Volume:

$64.17 Open:

$64.90 Close:

Hologic Inc. Website:

Hologic Inc. Logo

Ad

Trending Stock Alerts
RECENT HOLX NEWS
  • HOLX - Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

    Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2025 on Wednesday, July 30, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. ...

  • HOLX - Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

    Completed assessment of more than 2,800 patients highlights the profound impact of the test in helping to predict the likelihood of extended endocrine therapy benefit for patients with HR+ breast cancer to support more informed care decisions Hologic, Inc. (Nasdaq: HOLX) and its subsi...

  • HOLX - Hologic to Webcast Presentations at Upcoming Investor Conferences

    Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences: The 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20 at 9:30 a.m. Eastern Time (ET) in New York. William Blair’s 45 th ...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get HOLX Alerts

Get HOLX Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1